← FDA Drug Approvals (Drugs@FDA)
RISEDRONATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2014-06-13
Drug application
- FDA Application #
ANDA079215- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RISEDRONATE SODIUM
- Generic name
- Risedronate Sodium
- Active ingredients
- RISEDRONATE SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS USA
- First approval
- 2014-06-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown